On 5 October 2015, Life Science Developments Limited sold its copper project, changed its name and became a life science and biotech investment company and it also appointed Jim Mellon as a non-executive director.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.65 GBX | 0.00% | +6.45% | -13.16% |
05-22 | Powerhouse resolves claim; PCI-PAL wins court case | AN |
05-22 | Bradda Head Lithium Ltd Provides an Update on Work At Its Basin Project in Arizona | CI |
1st Jan change | Capi. | |
---|---|---|
-13.16% | 8.2M | |
+27.84% | 85.07B | |
+15.74% | 70.78B | |
-.--% | 28.7B | |
+52.72% | 10.09B | |
+12.88% | 9.13B | |
+14.60% | 8.54B | |
+0.20% | 7.5B | |
+28.80% | 6.04B | |
-41.90% | 5.41B |
- Stock Market
- Equities
- BHL Stock
- News Bradda Head Lithium Limited
- Life Science Developments Limited Appoints Jim Mellon as a Non-Executive Director